NovoCure Ltd Earnings Per Share Diluted

• NovoCure Ltd showed an increase of +21.8% in Earnings Per Share Diluted from 2024 to 2025.
• This data is from NovoCure Ltd's annual report (Form 10-K), filed with the SEC on February 26, 2026.
• XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 8 years of available data (2018 to 2025), NovoCure Ltd's Earnings Per Share Diluted has declined by 76.8%.
• Historical annual values: Fiscal year 2025: $1.22 (loss) per share | Fiscal year 2024: $1.56 (loss) per share | Fiscal year 2023: $1.95 (loss) per share | Fiscal year 2022: $0.88 (loss) per share | Fiscal year 2021: $0.56 (loss) per share | Fiscal year 2020: $0.18 per share | Fiscal year 2019: $0.07 (loss) per share | Fiscal year 2018: $0.69 (loss) per share.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026